Natalie J. Thornburg

Overview

Best Publications

• Aerosol and Surface Stability of SARS-CoV-2 as Compared with SARS-CoV-1.

  Neeltje van Doremalen;Trenton Bushmaker;Dylan H. Morris;Myndi G. Holbrook

  11720
  Citations

• Presymptomatic SARS-CoV-2 Infections and Transmission in a Skilled Nursing Facility.

  Melissa M. Arons;Kelly M. Hatfield;Sujan C. Reddy;Anne Kimball

  2362
  Citations

• An orally bioavailable broad-spectrum antiviral inhibits SARS-CoV-2 in human airway epithelial cell cultures and multiple coronaviruses in mice.

  Timothy P. Sheahan;Amy C. Sims;Shuntai Zhou;Rachel L. Graham

  1074
  Citations

• Seroprevalence of Antibodies to SARS-CoV-2 in 10 Sites in the United States, March 23-May 12, 2020.

  Fiona P. Havers;Carrie Reed;Travis Lim;Joel M. Montgomery

  772
  Citations

• US CDC Real-Time Reverse Transcription PCR Panel for Detection of Severe Acute Respiratory Syndrome Coronavirus 2.

  Xiaoyan Lu;Lijuan Wang;Senthilkumar K. Sakthivel;Brett Whitaker

  710
  Citations

• Severe Acute Respiratory Syndrome Coronavirus 2 from Patient with Coronavirus Disease, United States.

  Jennifer Harcourt;Jennifer Harcourt;Azaibi Tamin;Xiaoyan Lu;Shifaq Kamili

  641
  Citations

• The safety, immunogenicity, and acceptability of inactivated influenza vaccine delivered by microneedle patch (TIV-MNP 2015): a randomised, partly blinded, placebo-controlled, phase 1 trial

  Nadine G Rouphael;Michele Paine;Regina Mosley;Sebastien Henry

  478
  Citations

• Comparative Effectiveness of Moderna, Pfizer-BioNTech, and Janssen (Johnson & Johnson) Vaccines in Preventing COVID-19 Hospitalizations Among Adults Without Immunocompromising Conditions - United States, March-August 2021.

  Wesley H. Self;Mark W. Tenforde;Jillian P. Rhoads;Manjusha Gaglani;Manjusha Gaglani

  425
  Citations

• First 12 patients with coronavirus disease 2019 (COVID-19) in the United States

  Stephanie A. Kujawski;Karen K Wong;Jennifer P. Collins;Lauren Epstein

  350
  Citations

• Estimated SARS-CoV-2 Seroprevalence in the US as of September 2020.

  Kristina L. Bajema;Ryan E. Wiegand;Kendra Cuffe;Sadhna V. Patel

  319
  Citations

• 2020 taxonomic update for phylum Negarnaviricota (Riboviria: Orthornavirae), including the large orders Bunyavirales and Mononegavirales

  Jens H. Kuhn;Scott Adkins;Daniela Alioto;Sergey V. Alkhovsky

  279
  Citations

• Performance of an Antigen-Based Test for Asymptomatic and Symptomatic SARS-CoV-2 Testing at Two University Campuses - Wisconsin, September-October 2020.

  Ian W Pray;Laura Ford;Devlin Cole;Christine Lee

  275
  Citations

• Aerosol and surface stability of HCoV-19 (SARS-CoV-2) compared to SARS-CoV-1

  Neeltje Van Doremalen;Trenton Bushmaker;Dylan H. Morris;Myndi G. Holbrook

  248
  Citations

• Evaluation of Abbott BinaxNOW Rapid Antigen Test for SARS-CoV-2 Infection at Two Community-Based Testing Sites - Pima County, Arizona, November 3-17, 2020.

  Jessica L. Prince-Guerra;Olivia Almendares;Leisha D. Nolen;Jayleen K.L. Gunn

  243
  Citations

• SARS-CoV-2 Infections and Serologic Responses from a Sample of U.S. Navy Service Members - USS Theodore Roosevelt, April 2020.

  Daniel C. Payne;Sarah E. Smith-Jeffcoat;Gosia Nowak;Uzo Chukwuma

  243
  Citations

• Comparison of Home Antigen Testing With RT-PCR and Viral Culture During the Course of SARS-CoV-2 Infection.

  Unknown

  234
  Citations

• Activation of Nuclear Factor-κB p50 Homodimer/Bcl-3 Complexes in Nasopharyngeal Carcinoma

  Natalie J. Thornburg;Rajadurai Pathmanathan;Nancy Raab-Traub

  229
  Citations

• Seroprevalence of SARS-CoV-2 Among Frontline Health Care Personnel in a Multistate Hospital Network - 13 Academic Medical Centers, April-June 2020.

  Wesley H. Self;Mark W. Tenforde;William B. Stubblefield;Leora R. Feldstein

  223
  Citations

• Estimated US Infection- and Vaccine-Induced SARS-CoV-2 Seroprevalence Based on Blood Donations, July 2020-May 2021.

  Jefferson M Jones;Mars Stone;Hasan Sulaeman;Rebecca V Fink

  209
  Citations

• Household Transmission of Severe Acute Respiratory Syndrome Coronavirus-2 in the United States.

  Nathaniel M Lewis;Nathaniel M Lewis;Victoria T Chu;Dongni Ye;Erin E Conners

  165
  Citations

• Vaccine effectiveness of primary series and booster doses against covid-19 associated hospital admissions in the United States: living test negative design study

  Unknown

  164
  Citations

• Isolation and characterization of SARS-CoV-2 from the first US COVID-19 patient

  Jennifer Harcourt;Azaibi Tamin;Xiaoyan Lu;Shifaq Kamili

  158
  Citations

• Decline in SARS-CoV-2 Antibodies After Mild Infection Among Frontline Health Care Personnel in a Multistate Hospital Network-12 States, April-August 2020

  Wesley H Self;Mark W Tenforde;William B Stubblefield;Leora R Feldstein

  144
  Citations

• Change in Antibodies to SARS-CoV-2 Over 60 Days Among Health Care Personnel in Nashville, Tennessee.

  Manish M. Patel;Natalie J. Thornburg;William B. Stubblefield;H. Keipp Talbot

  135
  Citations